2025-01-012025-12-312025-12-31false11704678COSMOS HEALTHCARE LTD2026-05-1486900falseiso4217:GBPxbrli:pure117046782024-12-31117046782025-12-31117046782025-01-012025-12-31117046782023-12-31117046782024-12-31117046782024-01-012024-12-3111704678bus:SmallEntities2025-01-012025-12-3111704678bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3111704678bus:FullAccounts2025-01-012025-12-3111704678bus:PrivateLimitedCompanyLtd2025-01-012025-12-3111704678core:WithinOneYear2025-12-3111704678core:AfterOneYear2025-12-3111704678core:WithinOneYear2024-12-3111704678core:AfterOneYear2024-12-311170467812025-01-012025-12-3111704678core:ShareCapital2025-12-3111704678core:SharePremium2025-12-3111704678core:RevaluationReserve2025-12-3111704678core:OtherReservesSubtotal2025-12-3111704678core:RetainedEarningsAccumulatedLosses2025-12-3111704678core:ShareCapital2024-12-3111704678core:SharePremium2024-12-3111704678core:RevaluationReserve2024-12-3111704678core:OtherReservesSubtotal2024-12-3111704678core:RetainedEarningsAccumulatedLosses2024-12-3111704678core:LandBuildings2025-12-3111704678core:PlantMachinery2025-12-3111704678core:Vehicles2025-12-3111704678core:FurnitureFittings2025-12-3111704678core:OfficeEquipment2025-12-3111704678core:NetGoodwill2025-12-3111704678core:IntangibleAssetsOtherThanGoodwill2025-12-3111704678core:ListedExchangeTraded2025-12-3111704678core:UnlistedNon-exchangeTraded2025-12-3111704678core:LandBuildings2024-12-3111704678core:PlantMachinery2024-12-3111704678core:Vehicles2024-12-3111704678core:FurnitureFittings2024-12-3111704678core:OfficeEquipment2024-12-3111704678core:NetGoodwill2024-12-3111704678core:IntangibleAssetsOtherThanGoodwill2024-12-3111704678core:ListedExchangeTraded2024-12-3111704678core:UnlistedNon-exchangeTraded2024-12-3111704678core:LandBuildings2025-01-012025-12-3111704678core:PlantMachinery2025-01-012025-12-3111704678core:Vehicles2025-01-012025-12-3111704678core:FurnitureFittings2025-01-012025-12-3111704678core:OfficeEquipment2025-01-012025-12-3111704678core:NetGoodwill2025-01-012025-12-3111704678core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111704678core:ListedExchangeTraded2025-01-012025-12-3111704678core:UnlistedNon-exchangeTraded2025-01-012025-12-3111704678core:MoreThanFiveYears2025-01-012025-12-3111704678core:Non-currentFinancialInstruments2025-12-3111704678core:Non-currentFinancialInstruments2024-12-3111704678dpl:CostSales2025-01-012025-12-3111704678dpl:DistributionCosts2025-01-012025-12-3111704678core:LandBuildings2025-01-012025-12-3111704678core:PlantMachinery2025-01-012025-12-3111704678core:Vehicles2025-01-012025-12-3111704678core:FurnitureFittings2025-01-012025-12-3111704678core:OfficeEquipment2025-01-012025-12-3111704678dpl:AdministrativeExpenses2025-01-012025-12-3111704678core:NetGoodwill2025-01-012025-12-3111704678core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3111704678dpl:GroupUndertakings2025-01-012025-12-3111704678dpl:ParticipatingInterests2025-01-012025-12-3111704678dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3111704678core:ListedExchangeTraded2025-01-012025-12-3111704678dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3111704678core:UnlistedNon-exchangeTraded2025-01-012025-12-3111704678dpl:CostSales2024-01-012024-12-3111704678dpl:DistributionCosts2024-01-012024-12-3111704678core:LandBuildings2024-01-012024-12-3111704678core:PlantMachinery2024-01-012024-12-3111704678core:Vehicles2024-01-012024-12-3111704678core:FurnitureFittings2024-01-012024-12-3111704678core:OfficeEquipment2024-01-012024-12-3111704678dpl:AdministrativeExpenses2024-01-012024-12-3111704678core:NetGoodwill2024-01-012024-12-3111704678core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111704678dpl:GroupUndertakings2024-01-012024-12-3111704678dpl:ParticipatingInterests2024-01-012024-12-3111704678dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3111704678core:ListedExchangeTraded2024-01-012024-12-3111704678dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3111704678core:UnlistedNon-exchangeTraded2024-01-012024-12-3111704678core:NetGoodwill2025-12-3111704678core:IntangibleAssetsOtherThanGoodwill2025-12-3111704678core:LandBuildings2025-12-3111704678core:PlantMachinery2025-12-3111704678core:Vehicles2025-12-3111704678core:FurnitureFittings2025-12-3111704678core:OfficeEquipment2025-12-3111704678core:AfterOneYear2025-12-3111704678core:WithinOneYear2025-12-3111704678core:ListedExchangeTraded2025-12-3111704678core:UnlistedNon-exchangeTraded2025-12-3111704678core:ShareCapital2025-12-3111704678core:SharePremium2025-12-3111704678core:RevaluationReserve2025-12-3111704678core:OtherReservesSubtotal2025-12-3111704678core:RetainedEarningsAccumulatedLosses2025-12-3111704678core:NetGoodwill2024-12-3111704678core:IntangibleAssetsOtherThanGoodwill2024-12-3111704678core:LandBuildings2024-12-3111704678core:PlantMachinery2024-12-3111704678core:Vehicles2024-12-3111704678core:FurnitureFittings2024-12-3111704678core:OfficeEquipment2024-12-3111704678core:AfterOneYear2024-12-3111704678core:WithinOneYear2024-12-3111704678core:ListedExchangeTraded2024-12-3111704678core:UnlistedNon-exchangeTraded2024-12-3111704678core:ShareCapital2024-12-3111704678core:SharePremium2024-12-3111704678core:RevaluationReserve2024-12-3111704678core:OtherReservesSubtotal2024-12-3111704678core:RetainedEarningsAccumulatedLosses2024-12-3111704678core:NetGoodwill2023-12-3111704678core:IntangibleAssetsOtherThanGoodwill2023-12-3111704678core:LandBuildings2023-12-3111704678core:PlantMachinery2023-12-3111704678core:Vehicles2023-12-3111704678core:FurnitureFittings2023-12-3111704678core:OfficeEquipment2023-12-3111704678core:AfterOneYear2023-12-3111704678core:WithinOneYear2023-12-3111704678core:ListedExchangeTraded2023-12-3111704678core:UnlistedNon-exchangeTraded2023-12-3111704678core:ShareCapital2023-12-3111704678core:SharePremium2023-12-3111704678core:RevaluationReserve2023-12-3111704678core:OtherReservesSubtotal2023-12-3111704678core:RetainedEarningsAccumulatedLosses2023-12-3111704678core:AfterOneYear2025-01-012025-12-3111704678core:WithinOneYear2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3111704678core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3111704678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3111704678core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3111704678core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3111704678core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3111704678bus:Director12025-01-012025-12-3111704678bus:Director22025-01-012025-12-31

COSMOS HEALTHCARE LTD

(formerly COSMOS HEALTHCARE & BEAUTY LTD)

Registered Number
11704678
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

COSMOS HEALTHCARE LTD
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

AYDIN, Alptekin
HOCAOGLU, Funda

Registered Address

Cosmos Healthcare
33 London Road
Enfield
EN2 6DR

Registered Number

11704678 (England and Wales)
COSMOS HEALTHCARE LTD
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3108,76227,104
Tangible assets4205,950159,695
314,712186,799
Current assets
Debtors574,965355,155
Cash at bank and on hand38,07038,571
613,035393,726
Creditors amounts falling due within one year5(101,644)(144,861)
Net current assets (liabilities)511,391248,865
Total assets less current liabilities826,103435,664
Creditors amounts falling due after one year6(305,191)(99,917)
Provisions for liabilities8(34,095)-
Net assets486,817335,747
Capital and reserves
Called up share capital2,0002,000
Profit and loss account484,817333,747
Shareholders' funds486,817335,747
The financial statements were approved and authorised for issue by the Board of Directors on 14 May 2026, and are signed on its behalf by:
AYDIN, Alptekin
Director
HOCAOGLU, Funda
Director

Registered Company No. 11704678
COSMOS HEALTHCARE LTD
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Land and buildings-20
Plant and machinery25-
2.Average number of employees

20252024
Average number of employees during the year1417
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 January 2538,42038,420
Additions90,00090,000
At 31 December 25128,420128,420
Amortisation and impairment
At 01 January 2511,31611,316
Charge for year8,3428,342
At 31 December 2519,65819,658
Net book value
At 31 December 25108,762108,762
At 31 December 2427,10427,104
4.Tangible fixed assets

Land & buildings

Plant & machinery

Total

£££
Cost or valuation
At 01 January 2531,182294,178325,360
Additions-107,630107,630
At 31 December 2531,182401,808432,990
Depreciation and impairment
At 01 January 253,118162,547165,665
Charge for year1,55959,81661,375
At 31 December 254,677222,363227,040
Net book value
At 31 December 2526,505179,445205,950
At 31 December 2428,064131,631159,695
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables55,90040,722
Taxation and social security44,085103,189
Other creditors1,659950
Total101,644144,861
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts2,0887,004
Other creditors303,10392,913
Total305,19199,917
7.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts125,582-
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)34,095-
Total34,095-